Verily, an Alphabet precision health tech company, and L’Oréal, a leading household name in beauty, have announced the launch of the ‘My Skin & Hair Journey’ – a multi-year study to ena
Personalised and precision health is a firmly established concept in the development of new prescription medicines, but not so much in the consumer health category.
Alphabet subsidiary and precision health company Verily recently announced a breakthrough in its AI drug discovery GPCR research collaboration with Sosei Heptares.
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh